624 participants
Aumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Sensitizing EGFR Mutations
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-11-25
- Start Date:
- 2021-08-11
- Completion:
- 2024-06-18
Conditions
- Non-small Cell Lung Cancer
Interventions
- DRUG
No Results Yet